Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Expression data from age-dichotomized ER+ breast tumors
PubMed Full text in PMC Similar studies Analyze with GEO2R
Expression data of MCF7 cells following short-term E deprivation, ER-alpha siRNA knockdown and oxidant treatments
aCGH data from age-dichotomized ER+ breast tumors
Expression data from age-dichotomized ER+, N0 breast tumors
Expression data from MCF7 and BT474 cell lines after long term estrogen deprivation culture
Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer
Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms
Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers
PubMed Similar studies Analyze with GEO2R
Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor positive breast cancer
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [ChIP-seq]
PubMed Full text in PMC Similar studies
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [cell models RNA-seq]
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. [tumor samples RNA-seq]
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
PubMed Full text in PMC Similar studies SRA Run Selector
Identification of subtypes in HER2-positive breast cancer reveals a gene signature prognostic of outcome
Estrogen and progesterone receptor dynamics in patient-derived luminal breast cancer xenografts
ChIPseq analysis of patient-derived luminal breast cancer xenografts with progestins
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Gene profile of breast cancers with immunohistochemical phenotypes of ER+/- and/or HER2+/-
Genomic copy number alterations as predictive markers in breast cancer
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on